Cholesterol Drug Halves Heart Attack and Stroke in Early Test

02.09.2014 - An experimental cholesterol-lowering drug, alirocumab, from Sanofi and Regeneron Pharmaceuticals roughly cut in half the number of heart attacks and strokes in a clinical trial...